COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX. EUROPA: UNICREDIT, VINCI. Otra semana más con EE.UU. haciéndolo mejor Una semana más EE.UU. cierra en positivo mientras Asia registró caídas y Europa terminó con signo mixto donde el FTSE y el SMI fueron los mejores y el CAC y MIB los peores. Dentro del STOXX 600, Media y Farma lideraron las ganancias mientras que los Bancos fueron los que más cayeron (>-2,0%), seguidos de Viajes&Ocio y Autos. Por el lado macro, Eurozona los PMIs prelimin...
NEWS SUMMARY: CELLNEX. Another week with the US leading the way It was another week with the US closing in positive numbers, whereas Asia saw losses and Europe ended with mixed performance, where the FTSE and SMI were the best performers and the CAC and MIB the worst. In the STOXX 600, Media and Pharma led the gains, while Banks saw the biggest drops (more than -2.0%), followed by Travel & Leisure and Autos. On the macro side, in the euro zone November’s preliminary manufacturing and services P...
Rdos. 3T'24 vs 3T'23: Ventas: 838,0 M euros (-2,3% vs +9,7% BS(e) y +11,3% consenso); EBIT: 35,0 M euros (-18,6% vs +16,7% BS(e) y +16,3% consenso); BDI: 9,0 M euros (-52,6% vs +47,4% BS(e) y +36,8% consenso); Rdos. 9meses'24 vs 9meses'23: Ventas: 2.918 M euros (+6,7% vs +10,5% BS(e) y +11,0% consenso); EBIT: 137,0 M euros (+7,0% vs +18,9% BS(e) y +18,8% consenso); BDI: 61,0 M euros (+15,1% vs +50,9% BS(e) y +47,2% consenso);
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, CAF, CAIXABANK, COLONIAL, MERLIN. EUROPA: ASML, SANOFI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. El BCE con el objetivo casi cumplido El Euro STOXX 50 tuvo su mejor día desde finales de septiembre mientras las ...
NEWS SUMMARY: ACS, AENA, CAF, GREENING, NEINOR HOMES, REAL ESTATE SECTOR, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’24 results to be released over the coming days in Spain. Germany to hold elections in February The contagion from Asia, along with the increased geopolitical risk, dragged down European stock markets. In the STOXX 600, only Technology ended in gree...
>EBITDAaL just 0.7% and 0.9% above our estimates and the consensus - Cellnex’s Q3 2024 results were in line with our estimates and with the consensus at the operating level: revenues at € 982m (€ 987m ODDO BHF and € 982m css), with a slightly weaker performance from DAS and Services compensated by a better performance in France (probably partially impacted by the timing of the disposal of remedies within the quarter). An in-line performance in both opex and lease lia...
3Q'24 vs. 3Q'23 Results Sales: € 982.0 M (-2.5% vs. -2.8% BS(e) and -2.5% consensus); EBITDA: € 809.0 M (+6.7% vs. +6.2% BS(e) and +6.3% consensus); 9M'24 vs. 9M'23 Results Sales: € 2.903 Bn (-3.5% vs. -3.6% BS(e) and -3.5% consensus); EBITDA: € 2.387 Bn (+6.2% vs. +6.0% BS(e) and +6.0% consensus); Net Profit: € -140.0 M (€ -198.0 M in 9M'23);
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.